from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1800/PPE28

LFCtreatmentdescriptionclass of inhibitor

0.339

Amikacinug/mL Amikacintranslation

1.595

Cap5-10ug/mL Capreomycintranslation

2.204

Rox10-50 ug/mL Roxithromycintranslation

-1.156

SM2-5 ug/mL Streptomycintranslation

-0.116

Tet5-10 ug/mL Tetracyclinetranslation

-0.100

Rif0.2-5ug/mL Rifampicintranscription

-0.885

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.236

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.345

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.198

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.047

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.572

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.029

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.830

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.367

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.010

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.579

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.478

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.585

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.344

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.940

KCN5-20 ug/mL Potassium cyaniderespiration

0.228

NaN30.2-2 mM Sodium aziderespiration

-0.706

Nigericin50 uM Nigericinrespiration

-0.032

TRC10-150 ug/mL Triclosanrespiration

-0.543

TRZ10-25 ug/mL Thioridazinerespiration

-0.610

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

1.209

menadione6-10 ug/mL Menadionerespiration

-0.935

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.022

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.200

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.263

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.524

NRP_1Non-replicating persistence stage 1dosRassociated

0.380

Amp0.2mg/mL AmpicillincellWall

-0.209

Cephalexin20-100 ug/mL CephalexincellWall

0.346

Cerulenin0.32-5 ug/mL CerulenincellWall

0.050

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.445

EMB10-20 ug/mL EthambutolcellWall

0.931

Eta12-40 ug/mL EthionamidecellWall

0.270

INH0.2-0.4 ug/mL IsoniazidcellWall

0.633

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.232

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.347

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.267

BZA0.12 mg/mL BenzamidearomaticAmides

-0.027

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.190

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.187

H2O24 mM hydrogen peroxideDNAdamaging

-0.263

Levo10 ug/mL LevofloxacinDNAdamaging

-0.330

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.303

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.273

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.513

UVUV-irradiationDNAdamaging

-0.302

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.549

Antimycin12.5-50 ug/mL Antimycin A?

-0.299

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.194

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.683

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.491

PA8240.2-2 ug/mL PA-824?

0.479

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.280

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.004

Verapamil50 uM Verapamil?

0.094

mercaptoethanol2 mM 2-Mercaptoethanol?

0.109

methoxatin10-20 ug/mL Methoxatin?